Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

Introducing artificial intelligence for IVF directly at the point of care, revolutionizing the influence of extensive image and text data on business insights in reproductive medicine. We have gathered a team of the foremost specialists in artificial intelligence, IVF lab quality control/assurance, and digital technology solutions to develop this innovative platform, which boasts the largest open-source image database dedicated to embryology and andrology competency assessment globally. ART Compass emerges as the state-of-the-art IVF Lab Information Management System (LIMS), enhancing IVF lab quality management through artificial intelligence, all accessible via a user-friendly smartphone app. This platform allows for the evaluation of embryology and andrology competency assessments, as well as supports clinical decision-making in these fields. Users can also access annual procedure evaluation documentation, record new training for procedures, and onboard new staff seamlessly. Furthermore, it enables tracking of pregnancy outcomes for each IVF cycle while providing all necessary statistics. In addition, it facilitates management of patient cryostorage inventory and efficiently delivers preimplantation genetic testing results to physicians, ensuring a comprehensive approach to reproductive health. Ultimately, ART Compass is not just a tool; it represents a significant advancement in how IVF labs can operate and improve patient care.

Description

MIM Fertility is committed to improving the success rates of in vitro fertilization by leveraging artificial intelligence (AI) and data analytics. Our focus has been on creating AI solutions that empower IVF clinics to help patients realize their dreams of parenthood. We strive to redefine fertility care standards, aiming to transform the journey of infertility and ensure greater access to fertility solutions globally. Among our innovative offerings are AI-driven software platforms such as EMBRYOAID and FOLLISCAN. EMBRYOAID aids embryologists and physicians by quickly assessing the most promising embryos using images and time-lapse technology, which improves the embryo selection process for IVF. Meanwhile, FOLLISCAN serves as an ovarian follicular monitoring tool that effectively counts and measures follicles of varying sizes through 2D or 3D cine-loops of the ovaries, streamlining imaging ultrasonography workflows to boost diagnostic precision. By integrating advanced technology into fertility treatments, we believe we can significantly enhance patient experiences and outcomes.

API Access

Has API

API Access

Has API

Screenshots View All

Screenshots View All

Integrations

No details available.

Integrations

No details available.

Pricing Details

Free
Free Trial
Free Version

Pricing Details

No price information available.
Free Trial
Free Version

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Vendor Details

Company Name

ART Compass

Founded

2018

Country

United States

Website

artcompass.io

Vendor Details

Company Name

MIM Fertility

Founded

2015

Country

Poland

Website

www.mimfertility.ai/

Product Features

Product Features

Alternatives

Clarius Reviews

Clarius

Clarius Mobile Health

Alternatives

Join AI Reviews

Join AI

Miracle Advance Technologies